PharmaShots | Incisive News in 3 Shots

Subscribe Now

Type 1 SMA

Roche Publishes the Results of Evrysdi (risdiplam) in FIREFISH Study to Treat of Type 1 SMA at NEJM

Roche Publishes the Results of Evrysdi (risdiplam) in FIREFISH Study to Treat of Type 1 SMA at NEJM

July 30, 2021

Genentech Presents Results of Two-Year Data for Evrysdi (risdiplam) in Infants with Type 1 SMA at AAN2021

Genentech Presents Results of Two-Year Data for Evrysdi (risdiplam) in Infants with Type 1 SMA at AAN2021

April 15, 2021

Roche Reports Two-Year Data for Evrysdi (risdiplam) in Infants with Type 1 SMA

Roche Reports Two-Year Data for Evrysdi (risdiplam) in Infants with Type 1 SMA

September 28, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us